News | January 11, 2007

Women More Likely to Survive Lung Cancer

January 11, 2007 - NEW YORK (Reuters Health) - When women and men have lung cancer of the same stage and are given the same treatment, the women are more likely to survive, according to the findings published in the journal of Chest.
Lung cancer "is the number one cause of cancer deaths in both men and women worldwide," Dr. Robert James Cerfolio and colleagues from the University of Alabama at Birmingham, write.
Several studies using data from national cancer registries have shown that men and women differ in lung cancer survival. The present study was different in that it determined survival in men and women who were diagnosed with lung cancer, treated based on the same algorithm, and then followed for up to 7 years.
The study focused on patients with non-small cell lung cancer, the most common type. Unlike the small cell variant, non-small cell lung cancer is often amenable to surgical removal and more responsive to chemotherapy.
The study included 1,085 patients -- 671 men and 414 women. There were no significant differences between the sexes in terms of race, other diseases, smoking history, lung function and the treatment received.
At 5 years, 60 percent of women were still alive compared with 50 percent of men. Moreover, women had consistently higher survival rates for all stages of disease.
As to why survival was better for women, it may relate to them being more responsive to chemotherapy, Cerforlio and colleagues report.
The researchers conclude that the findings might help improve the "dismal" overall 5-year survival rate for patients with non-small lung cancer "by helping to target new therapeutic options."

SOURCE: Chest, December 2006.

http://news.yahoo.com/s/nm/20070112/hl_nm/lung_cancer_dc

Related Content

Brazil's Santa Casa Hospital System Chooses Carestream for Unified Diagnostic Workflow
News | PACS | May 22, 2019
Santa Casa de Misericordia has selected Carestream to replace its legacy diagnostic workflow technology across all...
MaxQ AI Launches Accipio Ax Slice-Level Intracranial Hemorrhage Detection
Technology | Computer-Aided Detection Software | May 21, 2019
Medical diagnostic artificial intelligence (AI) company MaxQ AI announced that Accipio Ax will begin shipping in August...
Life Image and Bialogics Analytics Partner to Deliver Imaging Business Intelligence
News | Analytics Software | May 21, 2019
Life Image and business intelligence analytics provider Bialogics Analytics have formed a strategic partnership that...
Tru-Vu Monitors Releases New Medical-Grade Touch Screen Display
Technology | Flat Panel Displays | May 17, 2019
Tru-Vu Monitors released the new MMZBTP-21.5G-X 21.5” medical-grade touch screen monitor. It is certified to both UL...
3 Recommendations to Better Understand HIPAA Compliance
Feature | Information Technology | May 17, 2019 | Carol Amick
According to the U.S.
The webinar "Realizing the Value of Enterprise Imaging: 5 Key Strategies for Success" will outline how to improve patient care, lower costs and reduce IT complexity through a well-designed enterprise Imaging strategy.  Change Healthcare
Webinar | Enterprise Imaging | May 16, 2019
The webinar "Realizing the Value of Enterprise Imaging: 5 Key Strategies for Success" will outline how to improve pat
FDA Clears Aidoc's AI Solution for Flagging Pulmonary Embolism
Technology | Artificial Intelligence | May 15, 2019
Artificial intelligence (AI) solutions provider Aidoc has been granted U.S. Food and Drug Administration (FDA)...
Icon Launches New Clinical Trial Patient Engagement Platform
Technology | Patient Engagement | May 14, 2019
Icon plc announced the release of its web-based clinical trial patient engagement platform, to provide patients with...
King's College London and NVIDIA Build U.K.'s First AI Platform for NHS Hospitals

King's College London will implement NVIDIA DGX-2 systems for AI research in the first phase of the project.

News | Artificial Intelligence | May 13, 2019
NVIDIA and King’s College London announced they are partnering to build an artificial intelligence (AI) platform that...
FDA Approves Zebra Medical Vision's HealthPNX AI Chest X-ray Triage Product
Technology | Artificial Intelligence | May 13, 2019
Zebra Medical Vision has received U.S. Food and Drug Administration (FDA) 510(k) clearance for HealthPNX, an artificial...